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Abstract
Objective: To investigate the association between energy drink (ED) use and sleep-
related disturbances in a population-based sample of young adults from the Raine
Study.
Design: Analysis of cross-sectional data obtained from self-administered question-
naires to assess ED use and sleep disturbance (Epworth Sleepiness Scale,
Functional Outcomes of Sleep Questionnaire (FOSQ-10) and the Pittsburgh
Sleep Symptoms Questionnaire–Insomnia (PSSQ-I)). Regression modelling was
used to estimate the effect of ED use on sleep disturbances. All models adjusted
for various potential confounders.
Setting: Western Australia.
Participants: Males and females, aged 22 years, from Raine Study Gen2–22 year
follow-up.
Results:Of the 1115 participants, 66 %were never/rare users (i.e.<once/month) of
ED, 17·0 % were occasional users (i.e. >once/month to <once/week) and 17 %
were frequent users (≥once/week). Compared with females, a greater proportion
of males used ED occasionally (19 % v. 15 %) or frequently (24 % v. 11 %). Among
females, frequent ED users experienced significantly higher symptoms of daytime
sleepiness (FOSQ-10: β= 0·93, 95 % CI 0·32, 1·54, P = 0·003) and were five times
more likely to experience insomnia (PSSQ-I: OR= 5·10, 95 % CI 1·81, 14·35,
P= 0·002) compared with never/rare users. No significant associations were
observed in males for any sleep outcomes.
Conclusions: We found a positive association between ED use and sleep disturb-
ances in young adult females. Given the importance of sleep for overall health, and
ever-increasing ED use, intervention strategies are needed to curb ED use in young
adults, particularly females. Further research is needed to determine causation and








Sleep is a fundamental biological requirement vital for
physical and mental health. Inadequate or reduced sleep
quality has wide-ranging negative effects on health
and everyday living(1,2). For example, sleeping <6–7 h/d
has been associated with increased risk of obesity(3),
diabetes(4), hypertension(5) and heart disease(1,6). Poor sleep
also reduces natural immune function, which increases the
risk of infections and even cancer(7). Insomnia and self-
reported poor sleep quality are associated with increased
risk of mortality(1,8,9). Sleep disturbances have also been†Georgina SA Trapp and Miriam Hurworth are co-first authors.
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reported to cause derangements in mood, concentration,
thinking, learning, memory, alertness and reaction times(10).
Such disturbances can affect daily living, work performance
and significantly increase the risk of road traffic accidents.
Ultimately, sleep disturbances produce a notable burden
on public health, social life and workplace functioning(1).
It is particularly common for young adults to experience
poor sleep quality or disturbed sleep(1,11–13). Many factors
can underlie this, including the presence of a sleep disorder
such as insomnia (defined as difficulty initiating and main-
taining sleep) and lifestyle behaviours(14). The 2016
Australian Sleep Health Survey, and the Sleep Health
Foundation’s recent report, found symptoms of excessive
daytime sleepiness (i.e. sleepiness, fatigue or feeling
irritable) were significantly more common among younger
age groups than older adults, with these problems occur-
ring in around half of 18–24-year-olds, twice the level of
those aged>65 years(1,15). Pathological daytime sleepiness,
where people describe a strong tendency to doze off, as
assessed by the Epworth Sleepiness Scale (ESS), was also
found to be significantly more common in younger adults
than in older adults, as was insomnia(1). Significant sex
differences also exist whereby difficulties related to
sleep onset and maintenance, insomnia and daytime
sleep-related symptoms are more common in females than
males(16–19).
Lifestyle behaviours, such as the consumption of caf-
feine, can also influence sleep negatively. Caffeine is a cen-
tral nervous system and cardiac stimulant which acts as an
antagonist to adenosine, a chemical that has been shown to
promote sleep and to influence autonomic nervous system
arousal(20). The consumption of caffeine-containing bever-
ages, such as coffee and tea, has been linked with sleep
disturbances. For example, double-blind randomised
controlled studies have shown that ingesting caffeinated
coffee, particularly in the evening, has significant negative
effects on sleep quality, sleep latency and frequency
of waking, compared with ingesting decaffeinated
coffee(21,22). Furthermore, the 2016 Australian Sleep
Health Survey found 61 % of adults who consumed six
or more cups of tea or coffee per d experienced two or
more sleep problems (i.e. difficulty falling asleep,
repeated overnight waking, daytime fatigue or exhaus-
tion, irritability or moodiness, or excess daytime sleepi-
ness (ESS > 10)), compared with 40 % of adults who did
not drink tea or coffee(1).
Energy drinks (ED) are another type of stimulant drink
which have the potential to affect sleep. ED are defined by
Food Standards Australia New Zealand as, ‘flavoured non-
alcoholic beverages to which other substances have been
added, that: (a) contain caffeine; and (b) have the purpose
of enhancing mental performance’(23). The use of these
drinks has increased dramatically amongst young people
over recent years. Indeed, ED represent the fastest growing
segment of the beverage market, with annual sales in
Australia increasing more than 600 % between 2001 and
2012(24). In 2015, it was reported that the global ED market
was worth 38·2 billion euro globally (approximately
55 billion AUD), with a further 40 % growth forecast by
2020(25).
Caffeine is a key ingredient in ED and is capped at
80 mg/250 ml (equivalent to an instant cup of coffee) in
Australia(23). However, other countries, such as the USA
and the UK, have no restrictions on the amount of caffeine
ED can contain. Aside from caffeine, other ingredients com-
monly found in ED include sugar, Na, B vitamins, amino
acids, colourings, flavourings and herbal stimulants, all of
which may act synergistically with the caffeine to enhance
its stimulatory effects(26–28). Current evidence shows that
adolescents (13–17 years) and young adults (18–34 years)
are the most frequent users of ED, with around a third to a
half reporting regular use(29–33). Amongst these age groups,
common reasons for consuming ED include helping them
stay up late to party, complete assignments or exams, work,
drive at night or long distances and for video game
sessions(34,35).
Despite the popularity of ED amongst young adults and
the high prevalence of sleep problems in this age group,
few studies have investigated the relationship between
ED consumption and sleep. Internationally, studies have
consistently reported positive associations between ED
use and sleep disturbances amongst college students from
a wide range of ethnic backgrounds including the USA(36),
the United Arab Emirates(37), Saudi Arabia(38), Chile(39),
Thailand(20) and Peru(40). However, the extent to which
behaviours in college populations reflect similar behav-
iours in the wider population is unclear. For example, com-
parative analysis studies conducted in Australia and the
USA have found significant demographic and behavioural
differences between college and non-college research
participants; college students participating in research
studies are more likely to be white, female, have attended
independent schools, have lower incomes, live with their
parents, be from higher socio-economic backgrounds
and be more risk-averse than their non-college counter-
parts(41–43). To date, only one study has investigated the
relationship between ED use and sleep disturbances
within a population-based sample. This US study found
ED use to be associated with an increased risk of difficulty
in falling and staying asleep, as well as insufficient duration
of sleep in males aged 20–34 years(44). This study highlights
the need for further research involving population-based
samples of both males and females in order to better
understand the relationship between ED use and sleep
disturbances in young adults. Furthermore, only two
studies to date have stratified their results by sex, which
is surprising given the differences in sleep patterns and risk
for sleep disturbances between males and females(16–19,44).
The purpose of this study, therefore, was to investigate the
association between ED use and sleep disturbances in a
population-based sample of young adults from the Raine
Study, and to stratify the results by sex.
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Methods
Participants
This study draws data from the Raine Study, which has col-
lected thousands of social, physical and medical measure-
ments on each participant from gestation to young
adulthood. Full details about the Raine Study have been
published elsewhere, see Newnham et al.(45) and Straker
et al.(46). Briefly, between 1989 and 1991, 2900 pregnant
women (at 16–20 weeks gestation) were recruited from
public and private antenatal clinics across Perth, Western
Australia. Living infants were born to 2804 (97 %) of these
women and owing to multiple births produced a cohort of
2868. This cohort and their families have been monitored
regularly. This study focuses on data from the cohort
(called Gen2 participants) when they were 22 years of
age (Gen2_22) as this was the only time point where ED
use and sleep data were both collected. Data collection
for the Gen2-22-year follow-up occurred during 2012 to
2014, and of the 2262 young adults eligible, 1234 (55 %)
participated. Socio-demographic variables measured at
birth were also used in the study.
Loss to follow-up
Details about cohort attrition have been published
previously(46–48). At the time of the Gen2-22 years follow-up,
565 of the cohort had withdrawn from the study, 41 had died
and 1029 had deferred or were lost to follow-up(46). Families
lost to follow-up were characterised by greater socio-
economic disadvantage at the time of enrolment compared
with families who continued in the study(46).
Assessment of energy drink use
Participants were asked about their frequency of ED intake
in a confidential self-report questionnaire. Usage options
were: never, <1 month, 1 d/month, 2 d/month, 3 d/month,
1 d/week, 2 d/week, 3 d/week, 4 d/week, 5 d/week,
6 d/week and every day. Responses were collapsed into
three usage categories: none/rare (never to≤once/month);
occasional (>once/month to <once/week) and frequent
(≥once/week).
Assessment of daytime sleepiness, sleep quality
and insomnia
Three validated self-administered questionnaires were used
to assess various sleep-related domains: the ESS, the
Functional Outcomes of Sleep Questionnaire (FOSQ-10)
and the Pittsburgh Sleep Symptoms Questionnaire–
Insomnia (PSSQ-I).
The ESS is widely used in the field of sleep medicine
as a subjective measure of an individual’s daytime
sleepiness(49). It consists of a list of eight different situations
where participants rate their usual chance of ‘dozing off’ or
falling asleep in recent times. The scales range from 0 (no
chance of dozing), 1 (slight chance of dozing), 2 (moderate
chance of dozing) to 3 (high chance of dozing). These
scores were added to provide a continuous ‘ESS Total
Score’ ranging from 0 to 24, where the higher the score,
the higher the level of daytime sleepiness. ESS scores
≥10 are considered to indicate that excessive daytime
sleepiness is present(50). Using this established cut-off, an
‘ESS Binary’ variable was also created where 0 indicated
excessive daytime sleepiness was not present and 1 indi-
cated excessive daytime sleepiness was present.
The FOSQ-10 is used to assess functional status resulting
from daytime sleepiness and has been used commonly as a
measure of sleep-related quality of life across five
subscales(51). Participants rate the difficulty they had in
undertaking ten everyday activities due to being too sleepy
or tired, including when operating a motor vehicle, watch-
ing a movie, or visiting family and friends.
Ratings are 0 (do not do this activity for other reasons), 4
(no difficulty), 3 (a little difficulty), 2 (moderate difficulty)
and 1 (extreme difficulty). The FOSQ-10 is measured con-
tinuously with a maximum possible score of 20. A lower
score indicates greater impact of daytime sleepiness on
daily activities. When scoring, an average score is calcu-
lated for each of the five subscales, these are totalled result-
ing in a total score. Responses from activities in which the
respondent does not do this activity ‘for other reasons’ are
not included in the average values for the subscales and
thus not used in the calculation of the total score either.
Of note, for the Gen2–22 years Raine Study follow-up,
the responses were reverse-coded; thus, the ratings in
the Raine questionnaire were 0 (do not do this activity),
1 (no difficulty), 2 (a little difficulty), 3 (moderate difficulty)
and 4 (extreme difficulty). Therefore, for this data set, a
higher score indicates greater impact of daytime sleepiness
on daily activities.
The PSSQ-I(52) (also known as the Insomnia Symptom
Questionnaire) was used to determine whether partici-
pants have an insomnia disorder. It comprises thirteen
self-rated questionswhere participants are asked to identify
how frequently they have experienced five common sleep
complaint symptoms during the prior month. Ratings were
0 (never), 1 (do not know), 2 (rarely – less than once a
week), 3 (sometimes – 1–2 times per week), 4 (frequently
– 3–4 times per week) and 5 (always – 5–7 times per week).
If a participant experienced any symptom, they were asked
to report how long each one had persisted in weeks,
months or years. Symptomatic participants were also asked
a further eight questions to determine how their sleep
affected daily life, with options for each item being 0
(not at all), 1 (a little bit), 2 (moderately), 3 (quite a bit)
and 4 (extremely). Answering ‘frequently’ or ‘always’ to
select sleep symptom criteria (i.e. having difficulty falling
asleep, difficulty staying asleep or feeling that your sleep
is unrefreshing), as well as having prolonged symptoms
(≥4 weeks), and responding ‘quite a bit’ or ‘extremely’ to
at least one daytime impairment question resulted in a diag-
nosis of insomnia disorder being assigned.
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Adjustment variables
Potential confounding variables included: family income at
birth (low income, i.e. AU$0–35 999 per annum v. high
income i.e. ≥AU$36 000 per annum); mother’s educational
qualification level at birth (school only v. post-school quali-
fication); highest education level completed at 22 years
(school only v. post-school); smoking status at 22 years
(yes v. no); alcohol consumption at 22 years (g/d ethanol),
measured via the self-administered Anti-Cancer Council of
Victoria Food Frequency Questionnaire(53); caffeine from
other sources (mg/d) including black and green tea, instant
and ground coffee and caffeinated soft drinks, measured
via the Anti-Cancer Council of Victoria Food Frequency
Questionnaire(53); physical activity at 22 years (met min/
week), assessed using the short-form of the International
Physical Activity Questionnaire(54); BMI at 22 years (weight
in kg divided by height in metres squared, measured
objectively by a trained research assistant using standard
calibrated equipment); depression, anxiety and stress
symptoms at 22 years, measured by the short-form depres-
sion, anxiety and stress scales (DASS-21)(55); andmarijuana,
stimulant, depressant and other recreational drug use at 22
years, assessed via self-report questionnaire with response
options coded as never/once, occasional (<weekly) or
frequent (≥weekly).
Statistical methods and control variables
Descriptive statistics were computed for all variables and
stratified by ED use and sex. When comparing frequent
v. none/rare categories of ED use, independent samples
t tests used for continuous variables and χ2 tests used for
categorical variables. Regression modelling was used to
estimate the association between ED use and sleep prob-
lems at age 22. Linear regression models were used for
the FOSQ-10 score, and logistic regression models for
the binary outcomes arising from the ESS and PSSQ-I.
Analyses were stratified by sex. All models included the
following covariates as potential confounders: family
income at birth; mother’s educational qualification level
at birth; highest education level completed; smoking status;
alcohol consumption; caffeine from other sources; physical
activity; BMI; DASS-21 depression, anxiety and stress
scores; and, marijuana, stimulant, depressant and other
recreational drug use.
Results
The sample characteristics and prevalence of ED use are
presented in Table 1. In total, 1115 participants from the
Raine Study (53·7 % females and 46·3 % males) provided
data on their ED use at the 22-year follow-up. Of these par-
ticipants, 66 % reported they never or rarely (i.e. ≤once/
month) used ED, 17·0 % reported they were occasional
users (i.e. >once/month to <once/week) and 17 %
reported they were frequent users (≥once/week). When
ED use was stratified by sex, a higher proportion of females
reported never or rarely using ED, compared with males
(74 % v. 57 %), whereas a higher proportion of males used
ED on an occasional (19 % v. 15 %) or frequent (24 % v.
11 %) basis.
In terms of the sleep domains for the whole sample, the
mean ESS total score was 5·7 ± 3·5 (range 0–19) and the
mean FOSQ-10 score was 7·2 ± 2·1 (range 0–16). Just over
7 % were classified as having an insomnia disorder as mea-
sured by the PSSQ-I, and 14·5 % were classified as having
excessive daytime sleepiness as measured by the ESS
binary variable. When stratified by sex, females scored
higher than males on all four sleep disturbance measures:
10·2 % of females v. 4 % of males were classified as having
an insomnia disorder as measured by the PSSQ–I; 16·1 % of
females v. 13 % ofmales were classified as having excessive
daytime sleepiness as measured by the ESS binary variable;
mean female FOSQ-10 scores were 7·5 ± 2·2, mean male
FOSQ-10 scores were 6·8 ± 2·1; mean female ESS total
scores were 6·1 ± 3·5 and mean male ESS total scores were
5·3 ± 3·5.
Table 2 presents the regression results of the association
between ED use and FOSQ-10 scores and PSSQ-I scores
(see online supplementary, Supplementary Table 2 for full
multivariate model results). In females, frequent ED users
(>1 week) had a significantly higher mean FOSQ-10 score
than rare users (adjusted β= 0·93, 95 % CI 0·32, 1·54,
P = 0·003), indicating a relatively impaired quality of life
due to daytime sleepiness. There was also a significantly
higher likelihood of insomnia in females as measured
by PSSQ-I (Adjusted OR = 5·10, 95 %CI 1·81, 14·35,
P = 0·002) for frequent ED users compared with rare users.
In males, no significant effects were observed for the
FOSQ-10 and PSSQ-I sleep outcomes.
Table 3 presents the regression results of the association
between ED use and ESS total scores and ESS binary scores
(see online supplementary, Supplementary Table 3 for
full multivariate model results). In females, there was a
statistically significant increased likelihood of excessive
sleepiness as measured by the ESS Total score (β= 1·19,
95 % CI 0·18, 2·20, P = 0·021) and ESS Binary score
(OR = 2·15, 95 % CI 0·91, 5·10, P= 0·081) in unadjusted
models for frequent users compared with never or rare
users. However, the significance of these associations
attenuated once confounding variables were adjusted for
(both P> 0·05). In males, no significant effects were
observed for the ESS total and binary score outcome
variables.
Discussion
This study investigated the association between EDuse and
sleep disturbances in a population-based sample of young
adult males and females from the Raine Study. Overall,
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Table 1 Sample characteristics at 22-year follow-up, stratified by sex and energy drink use†
Energy drink use – females Energy drink use – males
None or rare‡ (n 440) Occasional§ (n 91) Frequent|| (n 68) None or rare‡ (n 292) Occasional§ (n 98) Frequent|| (n 126)
Mean SD n % Mean SD n % Mean SD n % P* Mean SD n % Mean SD n % Mean SD n % P*
FOSQ-10 7·21 2·07 7·56 2·00 8·35 2·54 <0·001 6·85 2·05 6·73 1·46 6·89 2·01 0·86
ESS total score 5·98 3·50 5·75 2·60 7·17 4·40 0·021 4·86 3·15 5·41 3·35 5·52 3·76 0·079
Alcohol consumed
(g/week)
9·43 12·06 15·61 15·36 17·31 18·43 <0·001 17·07 19·12 22·91 19·24 26·39 24·16 <0·001
Activity (Met
min/week)
3020 2986 2376 2478 2698 3076 0·41 4384 3861 4242 3385 5581 4879 0·008
BMI (kg/m2) 25·5 6·6 25·1 5·7 26·3 5·8 0·38 24·9 4·7 24·5 3·6 26·2 5·1 0·017
Other caffeine (g/d) 0·133 0·134 0·162 0·146 0·190 0·190 0·003 0·152 0·194 0·162 0·142 0·161 0·150 0·63
DASS depression score 15·3 14·0 18·6 14·4 19·9 13·9 0·013 9·99 8·89 13·0 11·8 12·9 13·7 0·012
DASS anxiety score 17·7 16·3 21·3 16·1 23·7 16·5 0·006 11·8 11·9 13·9 14·3 14·6 14·8 0·044
DASS stress score 12·8 13·9 15·1 14·5 17·4 14·0 0·014 8·5 9·6 10·9 11·4 10·1 11·9 0·16
ESS≥ 10
Excessive sleepiness 54/352 15·3 6/76 7·9 15/53 28·3 0·022 26/253 10·3 10/86 11·6 17/117 14·5 0·24
PSSQ
Insomnia 26/352 7·4 6/75 8·0 14/53 26·4 <0·001 7/252 2·8 3/86 3·5 6/116 5·2 0·26
Income at birth
Low 135/430 31·4 28/89 31·5 27/67 40·3 0·15 86/286 30·1 34/94 36·2 41/120 34·2 0·42
Mother’s education
Post school 271/440 61·6 48/91 52·7 27/68 39·7 0·001 191/292 65·4 61/98 62·2 68/126 54·0 0·027
Education completed
Post-school 238/432 55·1 47/91 51·6 30/67 44·8 0·12 146/287 50·9 47/95 49·5 52/120 43·3 0·17
Smoker
Yes 43/440 9·8 14/91 15·4 27/68 39·7 <0·001 42/291 14·4 16/98 16·3 37/126 29·4 <0001
Marijuana use
Frequent 30/432 6·9 10/91 11·0 9/67 13·4 <0·001 33/286 11·5 15/96 15·6 21/123 17·1 0·12
Occasional 89/432 20·6 30/91 33·0 27/67 40·3 77/286 26·9 34/96 35·4 39/123 31·7
Stimulant use
Frequent 9/435 2·1 1/91 1·1 4/68 5·9 <0·001 7/287 2·4 2/96 2·1 7/123 5·7 0·23
Occasional 64/435 14·7 22/91 24·2 25/68 36·8 60/287 20·9 23/96 24·0 27/123 22·0
Depressant use
Frequent 3/435 0·7 0/91 0·0 0/68 0·0 0·20 0/287 0·0 0/96 0·0 0/122 0·0 0·043
Occasional 10/435 2·3 1/91 1·1 4/68 5·9 7/287 2·4 5/96 5·2 8/122 6·6
Other drug use
Frequent 2/435 0·5 0/91 0·0 0/68 0·0 <0·001 0/287 0·0 1/96 1·0 0/123 0·0 0·57
Occasional 21/435 4·8 6/91 6·6 13/68 19·1 36/287 12·50 13/96 3·5 18/123 14·6
FOSQ-10, Fundamental Outcomes of Sleep Questionnaire; ESS, Epworth Sleepiness Scale; DASS, Depression Anxiety Stress Scale; PSSQ – Insomnia, Pittsburgh Sleep Symptoms Questionnaire–Insomnia.
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Table 2 Regression results of the association between energy drink use and Fundamental Outcomes of Sleep Questionnaire (FOSQ-10) scores (linear regression), and Pittsburgh Sleep Symptoms
Questionnaire–Insomnia (PSSQ – insomnia) scores (logistic regression)*
FOSQ-10 PSSQ-I
Unadjusted Adjusted Unadjusted Adjusted
Effect estimate 95% CI P-value Effect estimate 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Females n 484 n 451 n 480 n 447
Energy drink use
Frequent† 1·13 0·52, 1·75 <0·001 0·93 0·32, 1·54 0·003 4·50 2·17, 9·34 <0·001 5·10 1·81, 14·35 0·002
Occasional‡ 0·35 −0·18, 0·87 0·20 0·13 −0·36, 0·61 0·61 1·09 0·43, 2·75 0·86 0·85 0·27, 2·64 0·78
None/rare§ Ref Ref Ref Ref
Males N 457 N 410 N 454 N 408
Energy drink use
Frequent† 0·039 −0·39, 0·47 0·86 −0·31 −0·79, 0·16 0·19 1·91 0·63, 5·81 0·26 0·21 0·02, 1·87 0·16
Occasional‡ −0·12 −0·60, 0·35 0·61 −0·31 −0·82, 0·20 0·23 1·26 0·32, 5·01 0·74 0·49 0·06, 4·14 0·51
None/rare§ Ref Ref Ref Ref




Table 3 Regression results of the association between energy drink use and Epworth Sleepiness Scale (ESS) total scores (linear regression) and ESS binary (logistic regression)*
ESS total score ESS binary
Unadjusted Adjusted Unadjusted Adjusted
Effect estimate 95% CI P-value Effect estimate 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Females n 481 n 448 n 481 n 448
Energy drink use
Frequent† 1·19 0·18, 2·20 0·021 0·95 −0·14, 2·03 0·086 2·19 1·12, 4·23 0·022 2·15 0·91, 5·10 0·081
Occasional‡ −0·23 −1·10, 0·64 0·60 −0·28 −1·14, 0·59 0·53 0·47 0·20, 1·14 0·096 0·47 0·18, 1·23 0·12
None/rare§ Ref Ref Ref Ref
Males n 456 n 410 n 456 n 410
Energy drink use
Frequent† 0·66 −0·08, 1·40 0·079 0·05 −0·79, 0·90 0·90 1·48 0·77, 2·86 0·24 0·96 0·44, 2·11 0·92
Occasional‡ 0·55 −0·28, 1·37 0·19 0·36 −0·55, 1·26 0·44 1·15 0·53, 2·49 0·50 1·31 0·58, 2·96 0·51
None/rare§ Ref Ref Ref
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there was a positive association between ED use and sleep
disturbances in young adult females, but not young
adult males.
These findings are consistent with several international
studies on college students which have reported positive
associations between ED use and poorer sleep quality,
longer sleep latency, shorter sleep duration, lower habitual
sleep efficiency and presence of insomnia. For example, in
a recent study involving 919 college students from the
United Arab Emirates, ED users were more than twice as
likely to report poor sleep quality compared with
non-users(37). AmongUS college athletes, Stasio et al. found
frequent ED use to be associated with poorer sleep quality,
longer sleep latency, shorter sleep duration and lower
habitual sleep efficiency(36). Similarly, in Velez et al.’s study
involving 832 Chilean college students, where poor sleep
quality was already prevalent, ED intake was associated
with greater odds of poor sleep quality(39). In Thailand,
ED use was shown to be significantly and positively asso-
ciated with poor sleep quality (OR 1·50; 95 % CI 1·28, 1·77)
in a large sample of college students (n 2854)(20). Similarly,
in a study involving 2458 Peruvian college students, ED use
was identified as risk factor for poor sleep quality(40), with
insomnia being the most frequently reported adverse effect
of ED use in females (while it was increased urination in
males)(38). To date, only one other population-based study
has investigated the relationship between ED use and sleep
disturbances in young adults. Our findings are in support of
this study which found ED use to be associated with an
increased risk in young adults of trouble going to, or stay-
ing, asleep(44).
There are a number of possible explanations for the pos-
itive relationship between ED use and sleep disturbances.
ED contain caffeine, an adenosine receptor antagonist,
which has action blocking receptors in the brain that help
regulate sleep and alertness(56,57). Numerous studies have
shown caffeine intake to disrupt sleep(21,57–59). Other ED
ingredients such as sugar, Na, B vitamins, amino acids, col-
ourings, flavourings and herbal stimulants may also act
synergistically with caffeine to enhance its stimulatory
effects(26–28). It is also possible that individuals experiencing
sleep disturbances turn to ED for temporary relief of day-
time sleepiness symptoms. Indeed, two-thirds of regular
ED users in a study of 496 US college students cited an inad-
equate amount of sleep as the most common reason for ED
intake(60).
Alternatively, it is possible that the relationship between
ED and sleep disturbances is bidirectional. A cyclical pat-
tern may exist whereby ED might be used to counter
daytime sleepiness; however, the ED then cause sleep dis-
ruption, resulting in poor functioning and more daytime
sleepiness which perpetuates the cycle of ED intake(61–63).
Evidence that ED may initiate sleep disturbances has been
reported in a study which surveyed 667 first year US college
students for up to 56 d each across four semesters yielding
information on 25 616 person-days. On days when students
used ED, they reported lower sleep quantity and quality that
night, and greater next-day tiredness, comparedwith days of
non-ED usage.
The current study found evidence of sex differences in
the relationship between ED use and sleep disturbances. In
young adult females (but not males), frequent ED users
experienced significantly reduced functional status result-
ing from drowsiness as measured by the FOSQ-10 score
and a significantly higher likelihood of insomnia as mea-
sured by the PSSQ-I, compared with none/rare users of
ED. In females, a significant association with ED intake
was found for the FOSQ-10 but not the ESS. This may be
related to the fact they are measuring different constructs:
daytime sleepiness in the case of the ESS and the effect of
daytime sleepiness on functional outcomes related to daily
behaviours and sleep-related quality of life. The reasons
underlying the lack of association between ED use and
sleep disturbances in young adult males are unclear. It
may be related to potential differences in caffeine metabo-
lism between males and females, including the influences
of sex hormones(64) or differences in body fat and body
weight(65). Few other studies have examined differences
between the sexes in the relationship between ED use
and sleep disturbances, and those that have report mixed
findings. For example, among members of the US military
services (n 183, 81 % males, median age 27), Waits et al.
did not find ED intake to be associated with insomnia in
either sex(66). However, this result may reflect the small
sample of females in this study and the different context
and setting within which the ED were used (i.e. during
active service). Larson et al.’s larger population-based
study found both sexes had trouble falling or staying asleep
after ED consumption, while only males had perceived
inadequate sleep(44).
Given that the current study, and others, has linked ED
use to sleep disturbances, it is important that there is more
research in this relatively new and growing area. Future
research could also employ more robust measures of sleep
disturbances, such as using objective measures including
actigraphy and polysomnography and try to elucidate
whether it is the frequency or the amount of consumption,
the type of ED, the individual or the combination of
components that have the greatest impact on sleep disturb-
ances. Finally, future research should incorporate longi-
tudinal study designs as these types of study designs are
needed to be able to draw conclusions regarding the causal
relationships in question.
The present findings have important implications for
policymakers, educators, health professionals and the gen-
eral public. Intervention strategies to curb ED use in young
adults, particularly females may be needed including more
education to inform young people about the ingredients
and potential harms associated with ED use, including their
potential role in initiating and exacerbating sleep disturb-
ances. Health promotion programmes should promote
alternative ways to increase daytime energy levels among
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young adults such as getting adequate sleep, eating a
nutritious diet and engaging in regular physical activity.
Practicing cliniciansmaywish to assess ED intake in routine
evaluations, particularly for young females presenting with
insomnia and excessive daytime sleepiness symptoms.
Finally, health professionals, parents and peers should be
aware of ED use as a possiblemarker for sleep disturbances
in young people, especially young adult females.
The findings of the current study should be interpreted
in light of several limitations. As ED data were not collected
in any earlier Raine cohort follow-ups, this study was lim-
ited by its cross-sectional study design which restricts the
ability to derive causation. Self-reported use of ED, alcohol
and illicit drugs were also relied upon. Whilst self-report
assessment has been established as a valid means for
assessing these behaviours and may lead to more honest
reporting than face-to-face assessment(67), the possibility
of individual over- or under-reporting cannot be dis-
counted. Not all confounding variables relating to sleep
were able to be adjusted for in modelling, for example,
medication use which might interfere with sleep was not
able to be controlled for, nor was night-time screen use,
which has been associated with sleep disturbances and
insufficient sleep duration(2,68). This issue may be particu-
larly relevant to this age group given 75 % of young adults
(18–24 years) in the 2016 Australian Sleep Health Survey
reported using the internet just prior to their bedtime on
most nights(1). Whilst it was a strength of this study to
use a large population-based sample, care needs to be
taken in generalising these results to the wider community
as participants included in the Gen2-22 years follow-up of
the Raine Study were more likely to be socio-economically
advantaged relative to participants lost to follow-up(46).
Replication of our results in other cohorts would help
address this concern. Despite these limitations, the results
from this study provide important information regarding
the association between ED use and sleep disturbances
among young adults, highlighting the presence of a rela-
tionship in females but not males.
Conclusion
This study found a positive association between ED use and
sleep disturbances in young adult females, but no associa-
tions were observed in young adult males. Given the impor-
tance of sleep for health and well-being, and the rise in ED
use, further research is needed to establish causality and the
possible mechanisms behind this relationship between ED
intake and sleep disturbances in young adult females and
intervention strategies to curb ED use in young adults.
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